PRIMARY SJOGREN'S SYNDROME
Clinical trials for PRIMARY SJOGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells aim to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage trial tests a new type of CAR-T cell therapy in 11 children with severe rheumatic diseases like juvenile dermatomyositis and arthritis that haven't improved with standard treatments. The therapy uses specially engineered immune cells to target and calm the overac…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
Engineered immune cells take on autoimmune diseases in early trial
Disease control Recruiting nowThis early-stage trial is testing a new treatment called OL-CD19-GDT, which uses specially engineered immune cells (CAR-T cells) from a healthy donor to target and destroy faulty immune cells in people with severe autoimmune diseases like systemic sclerosis and Sjogren's syndrome…
Matched conditions: PRIMARY SJOGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:33 UTC